2,3-Bisphosphoglyceric acid
2,3-Bisphosphoglyceric acid
2,3-Bisphosphoglyceric acid (2,3-BPG) is an important organic phosphate molecule found in red blood cells. It plays a crucial role in regulating the oxygen binding affinity of hemoglobin.
Structure
2,3-Bisphosphoglyceric acid is a three-carbon isomer of the glycolytic intermediate 1,3-bisphosphoglycerate. It contains two phosphate groups attached to the second and third carbon atoms of the glyceric acid backbone.
Function
2,3-BPG binds to deoxygenated hemoglobin, stabilizing it and reducing its affinity for oxygen. This facilitates the release of oxygen from hemoglobin in the tissues, enhancing oxygen delivery.
Role in Oxygen Transport
The presence of 2,3-BPG shifts the oxyhemoglobin dissociation curve to the right, indicating a lower affinity of hemoglobin for oxygen. This shift is crucial for efficient oxygen unloading in peripheral tissues.
Fetal Hemoglobin
Fetal hemoglobin (HbF) has a lower affinity for 2,3-BPG compared to adult hemoglobin (HbA). This difference allows fetal hemoglobin to have a higher affinity for oxygen, facilitating the transfer of oxygen from the maternal to the fetal circulation.
Metabolic Pathway
2,3-BPG is synthesized in red blood cells from 1,3-bisphosphoglycerate, an intermediate in the glycolysis pathway. The enzyme bisphosphoglycerate mutase catalyzes the conversion of 1,3-bisphosphoglycerate to 2,3-BPG.
Clinical Significance
Alterations in 2,3-BPG levels can affect oxygen delivery. For example, increased levels of 2,3-BPG are seen in conditions such as chronic hypoxia and anemia, enhancing oxygen release to tissues. Conversely, decreased levels can impair oxygen delivery.
Related pages
Chemical structure of 2,3-Bisphosphoglyceric acid
Pathway of generation of 2,3-bisphosphoglycerate
Oxyhemoglobin dissociation curve
Fetal hemoglobin has a higher affinity for oxygen than adult hemoglobin.
2,3-Bisphosphoglyceric acid structure
Pathway of generation of 2,3-bisphosphoglycerate
Oxyhaemoglobin dissociation curve
Fetal hemoglobin chart
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
